Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 4Uterine Cervical Dysplasia 2Neoplasms 2Precancerous Conditions 1Papilloma 1Neoplasms, Squamous Cell 1Neoplasms, Glandular and Epithelial 1Neoplasms by Histologic Type 1

Interventions

pembrolizumab 2Cisplatin 2Cetuximab 2zalutumumab 1poly ICLC 1enzalutamide 1abemaciclib 1Radiotherapy 1Papanicolaou Test 1Oxaliplatin 1Neoadjuvant Therapy 1Injections, Subcutaneous 1Human Papillomavirus DNA Tests 1High-Intensity Focused Ultrasound Ablation 1Gemcitabine 1Fluorouracil 1Everolimus 1Docetaxel 1Colposcopy 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neoplasms, Squamous Cell × Colposcopy × Clear all
NCT01234480 2023-05-16

Intended Use Study of the BD SurePath Plusâ„¢ Pap

Becton, Dickinson and Company

Terminated
5,859 enrolled 4 charts
Gynecologic

Uterine Cervical Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡